BlackRock Health Sciences Trust (NYSE:BME) Announces $0.26 Monthly Dividend

BlackRock Health Sciences Trust (NYSE:BME) declared a monthly dividend on Friday, January 2nd. Shareholders of record on Tuesday, January 20th will be given a dividend of 0.2621 per share on Friday, January 30th. This represents a c) annualized dividend and a dividend yield of 7.5%. The ex-dividend date of this dividend is Tuesday, January 20th.

BlackRock Health Sciences Trust Trading Down 0.2%

Shares of NYSE:BME opened at $41.79 on Friday. The stock has a fifty day moving average of $40.93 and a 200-day moving average of $38.28. BlackRock Health Sciences Trust has a one year low of $34.18 and a one year high of $42.46.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

A number of hedge funds and other institutional investors have recently modified their holdings of BME. Shaker Financial Services LLC acquired a new stake in BlackRock Health Sciences Trust during the 2nd quarter worth about $8,186,000. Cypress Capital Management LLC WY purchased a new position in shares of BlackRock Health Sciences Trust in the second quarter worth approximately $1,405,000. Bank of America Corp DE raised its holdings in shares of BlackRock Health Sciences Trust by 18.8% during the third quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after acquiring an additional 34,218 shares during the period. Consolidated Portfolio Review Corp raised its holdings in shares of BlackRock Health Sciences Trust by 40.2% during the third quarter. Consolidated Portfolio Review Corp now owns 54,522 shares of the company’s stock valued at $2,030,000 after acquiring an additional 15,643 shares during the period. Finally, Invesco Ltd. lifted its position in shares of BlackRock Health Sciences Trust by 7.6% in the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock valued at $8,085,000 after acquiring an additional 15,381 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.